迈得医疗
(688310)
| 流通市值：19.59亿 | | | 总市值：19.59亿 |
| 流通股本：1.64亿 | | | 总股本：1.64亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 269,358,450.1 | 159,924,358.14 | 39,857,551.99 | 447,418,984.29 |
| 营业总成本 | 331,653,537.35 | 201,090,679.93 | 70,531,168.22 | 414,721,751.3 |
| 其他经营收益 | | | | |
| 营业利润 | -47,581,122.24 | -32,162,171.31 | -23,980,800.6 | 59,419,224.9 |
| 利润总额 | -48,723,369.54 | -32,525,277.59 | -24,003,415.72 | 60,943,471.31 |
| 净利润 | -51,449,180.79 | -33,945,273.62 | -24,506,078.02 | 44,569,148.16 |
| 每股收益 | | | | |
| 其他综合收益 | 587,606.81 | 455,202.01 | 302,638.17 | -699,886.91 |
| 综合收益总额 | -50,861,573.98 | -33,490,071.61 | -24,203,439.85 | 43,869,261.25 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 601,621,548.01 | 586,677,117.18 | 628,332,591.38 | 709,311,212.52 |
| 非流动资产: | | | | |
| 非流动资产合计 | 489,079,235.05 | 489,097,546.98 | 487,894,783.89 | 476,140,819.72 |
| 资产总计 | 1,090,700,783.06 | 1,075,774,664.16 | 1,116,227,375.27 | 1,185,452,032.24 |
| 流动负债: | | | | |
| 流动负债合计 | 261,689,335.08 | 232,411,643.85 | 216,132,503.51 | 238,219,756.6 |
| 非流动负债: | | | | |
| 非流动负债合计 | 73,183,147.38 | 72,342,029.47 | 74,919,251.79 | 72,193,322.55 |
| 负债合计 | 334,872,482.46 | 304,753,673.32 | 291,051,755.3 | 310,413,079.15 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 773,042,031.53 | 775,641,791.33 | 817,685,354.54 | 862,077,412.15 |
| 股东权益合计 | 755,828,300.6 | 771,020,990.84 | 825,175,619.97 | 875,038,953.09 |
| 负债和股东权益合计 | 1,090,700,783.06 | 1,075,774,664.16 | 1,116,227,375.27 | 1,185,452,032.24 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 384,700,141.04 | 234,064,772.85 | 110,994,337.68 | 516,455,573.66 |
| 经营活动现金流出小计 | 424,767,113.59 | 251,619,130.49 | 138,235,791.08 | 365,238,094.6 |
| 经营活动产生的现金流量净额 | -40,066,972.55 | -17,554,357.64 | -27,241,453.4 | 151,217,479.06 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 605,106,263.61 | 468,199,692.93 | 50,289,481.55 | 945,311,614.63 |
| 投资活动现金流出小计 | 660,515,513.73 | 545,897,246.15 | 92,407,449.65 | 995,954,150.31 |
| 投资活动产生的现金流量净额 | -55,409,250.12 | -77,697,553.22 | -42,117,968.1 | -50,642,535.68 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 6,779,412.11 | 4,600,600 | 2,981,400 | 37,945,279.4 |
| 筹资活动现金流出小计 | 90,548,757.48 | 90,003,051.93 | 43,754,844.9 | 19,497,765.36 |
| 筹资活动产生的现金流量净额 | -83,769,345.37 | -85,402,451.93 | -40,773,444.9 | 18,447,514.04 |
| 汇率变动对现金及现金等价物的影响 | -1,005,410.3 | -1,162,878.28 | -1,041,184.28 | -800,572.14 |
| 现金及现金等价物净增加额 | -180,250,978.34 | -181,817,241.07 | -111,174,050.68 | 118,221,885.28 |
| 期末现金及现金等价物余额 | 46,820,742.41 | 45,410,547.38 | 115,897,669.93 | 227,227,788.45 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -181,817,241.07 | - | 118,221,885.28 |